Research-grade peptides · Third-party tested
K
RESEARCH USE ONLY: All products are for laboratory research purposes only. Not for human or animal consumption. By using this site, you confirm you are 21+ and acknowledge these products are not FDA approved.
← Back to Research Library

BPC-157 Research

Body Protection Compound
Category: Regenerative Medicine & Tissue Engineering CAS: 137525-51-0Formula: C62H98N16O22MW: 1419.53 g/mol Purity: ≥99.50% HPLC
View Product — $49.16

Mechanism of Action

BPC-157 is a synthetic pentadecapeptide derived from human gastric juice protein. It promotes healing through upregulation of the FAK-paxillin pathway and VEGF-mediated angiogenesis, activates the JAK-2/STAT-3 signaling cascade, enhances nitric oxide synthesis via the Akt-eNOS axis, and upregulates growth hormone receptor expression.

Key Research Findings

  • Accelerated tendon-to-bone healing with increased biomechanical strength in rat models
  • Cytoprotective effects on gastric mucosa with significant lesion reduction vs controls
  • Promoted angiogenesis and wound healing in diabetic wound models
  • Counteracted NSAID-induced gastrointestinal damage across multiple animal models
  • Systematic review confirmed improved musculoskeletal healing with no adverse effects

Peer-Reviewed Studies (5)

Chang CH, Tsai WC, et al.
Journal of Applied Physiology (2011)
BPC-157 promoted tendon fibroblast outgrowth, cell survival, and dose-dependent cell migration via FAK-paxillin activation
PMID: 21030672
Seiwerth S, Sikiric P, et al.
Current Pharmaceutical Design (2014)
Comprehensive review of BPC-157 angiogenic properties and vessel-healing potential across multiple models
PMID: 23782145
Staresinic M, Petrovic I, et al.
Journal of Orthopaedic Research (2003)
BPC-157 improved Achilles tendon recovery biomechanically, functionally, and microscopically
PMID: 14554208
Gwyer D, Wragg NM, Wilson SL
Cell and Tissue Research (2019)
Review confirming BPC-157 potential for soft tissue healing with no reported adverse reactions
PMID: 30915550
Sikiric P, Seiwerth S, et al.
Inflammopharmacology (2006)
Review of gastrointestinal effects including mucosal protection and IBD clinical trial progress
PMID: 17186181

Related Products

TB-500 SS-31
Research Disclaimer: The studies referenced above are from publicly available peer-reviewed literature. Pepta Labs products are sold strictly for research purposes. They are not intended for human consumption, therapeutic use, or as dietary supplements. All information is provided for educational and research reference only.